Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer

被引:0
|
作者
Cengiz Beyan
Esin Beyan
机构
[1] Ufuk University Faculty of Medicine,Department of Internal Medicine
[2] University of Health Sciences,undefined
[3] Kecioren Training and Research Hospital,undefined
来源
International Journal of Clinical Oncology | 2020年 / 25卷
关键词
Drug therapy; Mean platelet volume; Predictive value of tests; Prognosis; Prostatic neoplasms;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2175 / 2176
页数:1
相关论文
共 50 条
  • [31] Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer
    Sharifi, Marina N.
    Feng, Eric
    Rydzewski, Nicholas R.
    Taylor, Amy K.
    Sperger, Jamie M.
    Shi, Yue
    Helzer, Kyle T.
    Bootsma, Matthew L.
    Carreno, Viridiana
    Chang, Alex H.
    Nunamaker, Luke A.
    Blitzer, Grace C.
    Shang, Tianfu Andy
    Subramanian, Aishwarya
    Bjartell, Anders
    Josefsson, Andreas
    Wikstrom, Pernilla
    Feng, Emily
    Kohli, Manish
    Yang, Rendong
    Dehm, Scott M.
    Small, Eric J.
    Aggarwal, Rahul
    Quigley, David A.
    Lang, Joshua M.
    Zhao, Shuang G.
    Sjostrom, Martin
    MOLECULAR ONCOLOGY, 2025,
  • [32] Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
    Coleman, Ilsa M.
    DeSarkar, Navonil
    Morrissey, Colm
    Xin, Li
    Roudier, Martine P.
    Sayar, Erolcan
    Li, Dapei
    Corey, Eva
    Haffner, Michael C.
    Nelson, Peter S.
    CLINICAL CANCER RESEARCH, 2022, 28 (14) : 3127 - 3140
  • [33] Physician preferences for non-metastatic castration-resistant prostate cancer treatment
    Srinivas, Sandy
    Mohamed, Ateesha F.
    Appukkuttan, Sreevalsa
    Botteman, Marc
    Ng, Xinyi
    Joshi, Namita
    Horodniceanu, Erica
    Waldeck, A. Reginald
    Simmons, Stacey J.
    BMC UROLOGY, 2020, 20 (01)
  • [34] Prognostic role of chromogranin A in castration-resistant prostate cancer: a meta-analysis
    Hong, Peng
    Guo, Run-Qi
    Song, Gang
    Yang, Kai-Wei
    Zhang, Lei
    Li, Xue-Song
    Zhang, Kai
    Zhou, Li-Qun
    ASIAN JOURNAL OF ANDROLOGY, 2018, 20 (06) : 561 - +
  • [35] Physician preferences for non-metastatic castration-resistant prostate cancer treatment
    Sandy Srinivas
    Ateesha F. Mohamed
    Sreevalsa Appukkuttan
    Marc Botteman
    Xinyi Ng
    Namita Joshi
    Erica Horodniceanu
    A. Reginald Waldeck
    Stacey J Simmons
    BMC Urology, 20
  • [36] Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study
    Angusti, Tiziana
    Di Stefano, Rosario F.
    Parente, Antonella
    Bungaro, Maristella
    Turco, Fabio
    Samuelly, Alessandro
    Pisano, Chiara
    Scagliotti, Giorgio, V
    Di Maio, Massimo
    Tucci, Marcello
    Buttigliero, Consuelo
    MINERVA UROLOGY AND NEPHROLOGY, 2022, 74 (06): : 703 - 713
  • [37] Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer
    Zhang, Xue
    Nakajima, Kenichi
    Mizokami, Atsushi
    Horikoshi, Hiroyuki
    Nishimoto, Koshiro
    Hashine, Katsuyoshi
    Matsuyama, Hideyasu
    Takahashi, Satoru
    Wakabayashi, Hiroshi
    Kinuya, Seigo
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (06) : 428 - 440
  • [38] Mean platelet volume may not be associated with the prognosis of oral cancer
    Beyan, Cengiz
    Beyan, Esin
    ENT-EAR NOSE & THROAT JOURNAL, 2022,
  • [39] Efficacy of cabazitaxel in patients with metastatic castration-resistant prostate cancer: A single-center study in Japan
    Yamamoto, Yoshiyuki
    Ishii, Makoto
    Yoshimura, Akihiro
    Hayashi, Takuji
    Kawamura, Norihiko
    Nagahara, Akira
    Nakai, Yasutomo
    Nakayama, Masashi
    Kakimoto, Ken-ichi
    Nishimura, Kazuo
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (01) : 20 - 27
  • [40] How to approach castration-resistant prostate cancer?
    Bavbek, Sevil
    MARMARA MEDICAL JOURNAL, 2015, 28 (04): : 24 - 34